Ensaio em fase de recrutamento = ; Ensaio a decorrer = ; Ensaio concluído = ; Financiado por um membro do IRDiRC = ; Membro de uma ERN =

Ensaio (s) clínico (s) nacional (is)

ALEMANHA

Baden-Württemberg
FREIBURG

Can treatment with human growth hormone increase strength in spinal muscular atrophy type II and III (phase II study)?

Zentrum für Kinder- und Jugendmedizin Freiburg

Klinik für Neuropädiatrie und Muskelerkrankungen

Mais detalhes

BELGICA

ANTWERPEN
EDEGEM (ANTWERPEN)

Efficacy and Safety of a 4 Year Combination Therapy of Growth Hormone and Gonadotropin- Releasing Hormone Agonist in Children With a Short Predicted Height

Antwerp University Hospital - UZA

Kindergeneeskunde/Pediatrics

Mais detalhes

ESPANHA

Cataluña
ESPLUGUES DE LLOBREGAT

A Randomised, Open-labelled, Active-controlled, Multinational, Dose-escalation Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (NNC0195-0092) [...] to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency - ES (completed)

Hospital Sant Joan de Déu Barcelona

Servicio de Endocrinología

Mais detalhes

ESPANHA

Madrid
ADDRESS: NOT PROVIDED - ES

A randomised, open-labelled, single dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics of pegylated long-acting human growth hormone (NNC126-0083) compared to norditropin NordiFlex® in growth hormone deficient children (Phase II) (terminated)

Institution: Information not provided - ES

Mais detalhes

FRANCA

HAUTS-DE-FRANCE
ADDRESS: NOT PROVIDED - FR

A Randomised, Open-labelled, Active-controlled, Multinational, Dose-escalation Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (NNC0195-0092) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency (Phase I) - FR

Institution: Information not provided - FR

Mais detalhes